Prostate Cancer - Results from #22960

A negative confirmatory biopsy among men on active surveillance for prostate cancer does not protect them from histologic grade progression - Abstract June 20, 2013

Impact of experience and technical changes on acute urinary and rectal morbidity in low-dose prostate brachytherapy using loose seeds real-time implantation - Abstract June 20, 2013

Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: Oncologic outcomes and morbidity in 1002 patients - Abstract June 20, 2013

Breast and prostate cancer survivors in a diabetic cohort: Results from the Living With Diabetes study - Abstract June 20, 2013

Technology diffusion and diagnostic testing for prostate cancer - Abstract June 20, 2013

Risk of urinary incontinence following post-brachytherapy transurethral resection of the prostate (TURP) and correlation with clinical and treatment parameters - Abstract June 20, 2013

Diagnostic and outcome differences between heterosexual and nonheterosexual men treated for prostate cancer - Abstract June 19, 2013

Use of a clinical assistant to screen patients with genitourinary cancer to encourage entry into clinical trials and use of supportive medication: A pilot project at a Canadian cancer center - Abstract June 19, 2013

Castration-resistant prostate cancer: AUA Guideline - Abstract June 19, 2013

Defining high-risk prostate cancer - Abstract June 19, 2013

Results of hormone therapy as first-line treatment for high-risk prostate cancer - Abstract June 19, 2013

Future prospects: Who is the patient who still dies of prostate cancer following local treatment of high-risk prostate cancer? Can we prolong their lives using modern treatment approaches? - Abstract June 19, 2013

Biopsy-proven brain metastases from prostate cancer: A series of four cases with review of the literature - Abstract June 19, 2013

Assessment of endothelial dysfunction by flow-mediated dilatation in men on long-term androgen deprivation therapy (ADT) for prostate cancer - Abstract June 19, 2013

MRI-based sector analysis enhances prostate palladium-103 brachytherapy quality assurance in a phase II prospective trial of men with intermediate-risk localized prostate cancer - Abstract June 19, 2013

Stereotactic body radiotherapy for localized prostate cancer: Disease control and quality of life at 6 years - Abstract June 19, 2013

"We remain very much the second sex": The constructions of prostate cancer in popular news magazines, 2000-2010 - Abstract June 18, 2013

Longitudinal comparison of quality of life after real-time tumor-tracking intensity-modulated radiation therapy and radical prostatectomy in patients with localized prostate cancer - Abstract June 18, 2013

The future of systemic therapies for localised prostate cancer - Abstract June 18, 2013

Bone markers for monitoring efficacy in patients with bone metastases receiving zoledronic acid: A review of published data - Abstract June 18, 2013

Page 1149 of 1438